OncoSec Medical to Present Corporate Update at Biotech Showcase 2014

OncoSec Medical to Present Corporate Update at Biotech Showcase 2014

16 January 2014,   By ,   0 Comments

SAN DIEGO – January 7, 2014 — OncoSec Medical Inc. (OTCQB: ONCS), a biotechnology company developing its advanced-stage ImmunoPulse DNA-based immunotherapy to treat solid tumors, today announced that Punit Dhillon, President and CEO, will provide a corporate update at Biotech Showcase 2014; one of the world’s largest life sciences conferences held annually in San Francisco.

The presentation is scheduled to take place on Tuesday, January 14 at 2:30 p.m. PST at the Parc 55 Wyndham San Francisco–Union Square, located at 55 Cyril Magnin Street. A live webcast will be available by visiting the following link: http://www.media-server.com/m/p/byw47js4.

About Biotech Showcase 2014

Biotech Showcase™ is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences. Investors and biopharmaceutical executives from around the world gather in San Francisco during this critical week, which is widely viewed as setting the tone for the coming year.

Now in its sixth year, Biotech Showcase is expected to attract upwards of 1,700 attendees. The program includes lunch plenary sessions featuring top industry leaders and innovators speaking on industry and time-relevant topics, as well as presentations from both private and public companies.

 


Real Time Web Analytics